维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Adeyinka T"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Aetivated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression 显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
2	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
3	Surgical management of severe chronic constipation 显示文摘	CLAYDEN GS ADEYINKA T KUFEJI D	2010	Arch Dis Child2010，95，11：	1
4	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
5	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
6	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
7	Activated mitogen-activated kinase expression during human breast tumorigenesis and breast cancer Progression显示文摘	Nui Y Cherlet T	2002	Clinical Cancer Research2002，8，：	1
8	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression 显示文摘	ADEYINKA A NUI Y CHERLET T	2002	Clin Cancer Res2002，8，6：	1
9	Activated mitogen-activatedprotein kinase expression during human breast tumorigenesis andbreast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
10	Activated mitogen -activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
11	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression 显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
12	Phospho- Serine-118 estrogen receptor alpha detection in human breast tumors in vivo显示文摘	Murphy LC Cherlet T Adeyinka A	2004	Clin Cancer Res2004，10，4：	1
13	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
14	Surgical management of severe chronic constipation 显示文摘	Clayden GS Adeyinka T Kufeji D	2010	Arch Dis Child2010，95，11：	1
15	A proposed model for eval- uating the success of WebCT course content management system 显示文摘	ADEYINKA T MUTULA S	2010	Computers in Human Behavior2010，26，6：	1
16	Surgicalmanagement of severe chronic constipation 显示文摘	Clayden GS Adeyinka T Kufeji D	2010	Arch Dis Child2010，95，：	1
17	Activated mitogen activated protein kinase expression during human breast tumorigenesis and breast cancer progression 显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
18	Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，：	1
19	Activated mitogen activated protein kinase expression during human breast tumorigen esis and breast cancer progression显示文摘	Adeyinka A Nui Y Cherlet T	2002	Clin Cancer Res2002，8，6：	1
20	Race and colorectal cancer screening compliance among persons with a family history of cancer显示文摘AIM: To determine compliance to colorectal cancer(CRC) screening guidelines among persons with a family history of any type of cancer and investigate racial differences in screening compliance.METHODS: We used the 2007 Health Information National Trends Survey and identified 1094(27.4%)respondents(weighted population size = 21959672) without a family history of cancer and 3138(72.6%) respondents(weighted population size = 58201479) with a family history of cancer who were 50 years and older. We defined compliance with CRC screening as the use of fecal occult blood testing within 1 year, sigmoidoscopy within 5 years, or colonoscopy within 10 years. We compared compliance with CRC screening among those with and without a family member with a history of cancer. RESULTS: Overall, those with a family member with cancer were more likely to be compliant with CRC screening(64.9% vs 55.1%; OR = 1.45; 95%CI: 1.20-1.74). The absolute increase in screening rates associated with family history of cancer was 8.2% among whites. Hispanics had lowest screening rates among those without family history of cancer 41.9% but had highest absolute increase(14.7%) in CRC screening rate when they have a family member with cancer. Blacks had the lowest absolute increase in CRC screening(5.3%) when a family member has a known history of cancer. However, the noted increase in screening rates among blacks and Hispanics when they have a family member with cancer were not higher than whites without a family history of cancer:(54.5% vs 58.7%; OR = 1.16; 95%CI: 0.72-1.88) for blacks and(56.7% vs 58.7%; OR = 1.25; 95%CI: 0.72-2.18) for Hispanics.CONCLUSION: While adults with a family history of any cancer were more likely to be compliant with CRC screening guidelines irrespective of race/ethnicity, blacks and Hispanics with a family history of cancer were less likely to be compliant than whites without a family history. Increased burden from CRC among blacks may be related to poor uptake of screening among high-risk groups.	Adeyinka O Laiyemo Nicole Thompson Carla D Williams Kolapo A Idowu Kathy Bull-Henry Zaki A Sherif Edward L Lee Hassan Brim Hassan Ashktorab Elizabeth A Platz Duane T Smoot	2015	World Journal of Gastrointestinal Endoscopy2015，7，18：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示